Center for Melanoma Research and Treatment and Department of Surgery, California Pacific Medical Center, San Francisco, CA, USA.
Clin Exp Metastasis. 2012 Oct;29(7):775-96. doi: 10.1007/s10585-012-9521-1. Epub 2012 Aug 15.
The survival rates of melanoma, like any type of cancer, become worse with advancing stage. Spectrum theory is most consistent with the progression of melanoma from the primary site to the in-transit locations, regional or sentinel lymph nodes and beyond to the distant sites. Therefore, early diagnosis and surgical treatment before its spread is the most effective treatment. Recently, new approaches have revolutionized the diagnosis and treatment of melanoma. Genomic profiling and sequencing will form the basis for molecular taxonomy for more accurate subgrouping of melanoma patients in the future. New insights of molecular mechanisms of metastasis are summarized in this review article. Sentinel lymph node biopsy has become a standard of care for staging primary melanoma without the need for a more morbid complete regional lymph node dissection. With recent developments in molecular biology and genomics, novel molecular targeted therapy is being developed through clinical trials.
黑色素瘤的存活率与任何类型的癌症一样,随着分期的进展而恶化。光谱理论最符合黑色素瘤从原发部位向转移部位、区域或前哨淋巴结及远处转移部位发展的过程。因此,早期诊断和在其扩散之前进行手术治疗是最有效的治疗方法。最近,新方法彻底改变了黑色素瘤的诊断和治疗。基因组分析和测序将为未来更准确地对黑色素瘤患者进行亚组分类奠定分子分类学的基础。本文综述了转移分子机制的新见解。前哨淋巴结活检已成为无需要进行更具侵袭性的完整区域淋巴结清扫术的原发性黑色素瘤分期的标准治疗方法。随着分子生物学和基因组学的最新发展,通过临床试验正在开发新的分子靶向治疗。